Regeneron Pharmaceuticals Inc. (REGN)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Yancopoulos Officer, Director	$133.95	100	$13,395.00	866,106	2012-05-01	Filing
Aberman Officer	$135.29	2,300	$311,167.00	10,000	2012-05-01	Filing
Aberman Officer	$134.52	3,862	$519,516.24	12,300	2012-05-01	Filing
Van Officer	$136.42	13,143	$1,792,968.06	9,568	2012-04-30	Filing
Van Officer	$135.94	1,299	$176,586.06	22,711	2012-04-30	Filing
Baker Director	$125.00	12,910	$1,613,750.00	9,590	2012-04-19	Filing
Baker Director	$125.00	2,090	$261,250.00	9,590	2012-04-17	Filing
Yancopoulos Officer, Director	$121.09	1,010	$122,300.90	866,206	2012-03-26	Filing
Yancopoulos Officer, Director	$120.21	32,140	$3,863,549.40	867,216	2012-03-26	Filing
Goldstein Director	$120.00	5,000	$600,000.00	0	2012-03-26	Filing
Goldstein Director	$115.00	5,000	$575,000.00	0	2012-03-15	Filing
Goldstein Director	$111.06	400	$44,424.00	0	2012-03-15	Filing
Goldstein Director	$110.77	4,600	$509,542.00	0	2012-03-15	Filing
Brown Director	$104.32	2,700	$281,664.00	14,662	2012-03-01	Filing
Brown Director	$103.39	7,300	$754,747.00	14,662	2012-03-01	Filing
Brown Director	$103.06	5,000	$515,300.00	14,662	2012-03-01	Filing
Brown Director	$103.01	626	$64,484.26	14,662	2012-03-01	Filing
Brown Director	$102.65	4,374	$448,991.10	14,662	2012-03-01	Filing
Shooter Director	$104.05	400	$41,620.00	0	2012-02-23	Filing
Shooter Director	$103.51	9,600	$993,696.00	400	2012-02-23	Filing